Characteristics of Patients with Persistent COVID-19 Symptoms and Unscheduled Return Visits to a Centre for COVID-19 Evaluation.

IF 2.9 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Diseases (Basel, Switzerland) Pub Date : 2024-08-30 DOI:10.3390/diseases12090199
Silvia Nica, Remus Iulian Nica, Horia Alexandru Nica, Daniela Miricescu, Mohamed Abuzied Ali Khattab Abdelfatah, Oana Maria Schiopu, Ioan Cristian Nedelcu, Danut Gheorghe Cimponeriu, Constantin Stefani, Iulia-Ioana Stanescu-Spinu, Mariana Cătălina Ciornei
{"title":"Characteristics of Patients with Persistent COVID-19 Symptoms and Unscheduled Return Visits to a Centre for COVID-19 Evaluation.","authors":"Silvia Nica, Remus Iulian Nica, Horia Alexandru Nica, Daniela Miricescu, Mohamed Abuzied Ali Khattab Abdelfatah, Oana Maria Schiopu, Ioan Cristian Nedelcu, Danut Gheorghe Cimponeriu, Constantin Stefani, Iulia-Ioana Stanescu-Spinu, Mariana Cătălina Ciornei","doi":"10.3390/diseases12090199","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> This retrospective study aimed to evaluate the characteristics of patients with long COVID syndrome. <b>Methods:</b> This study included 457 adults who had at least one persistent symptom after COVID-19 infection. <b>Results:</b> The median time interval between the last SARS-CoV-2 infection and emergency room presentation was 3 months. Older patients had comorbidities (61.7 vs. 44.9 years, <i>p</i> < 0.0001), moderate or severe forms of COVID-19 (61.2 vs. 50.9 years, <i>p</i> < 0.0001), and respiratory symptoms (56.1 vs. 52.0 years, <i>p</i> = 0.0027). Non-vaccinated patients were older than vaccinated patients (56.0 vs. 51.5 years, <i>p</i> = 0.0008) and had residual lung abnormalities following COVID-19 infection (51.5% vs. 36.8%, <i>p</i> < 0.003). The time interval between the last SARS-CoV-2 infection and the hospital evaluation was shorter for vaccinated patients (3.2 vs. 3.9 months, <i>p</i> < 0.0001) and those with mild forms (3.3 vs. 4.12 months, <i>p</i> = 0.0001) versus non-vaccinated individuals. After the last SARS-CoV-2 infection, 107 patients developed impaired fasting glucose, impaired glucose tolerance, or diabetes mellitus, being patients with already known chronic diseases (<i>p</i> = 0.0002), or hypertension (<i>p</i> = 0.001). <b>Conclusions:</b> Our study pointed out the heterogeneity of symptoms following COVID-19, and they are associated with age, vaccination status, or severity of SARS-CoV-2 infection.</p>","PeriodicalId":72832,"journal":{"name":"Diseases (Basel, Switzerland)","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11431115/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diseases (Basel, Switzerland)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/diseases12090199","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: This retrospective study aimed to evaluate the characteristics of patients with long COVID syndrome. Methods: This study included 457 adults who had at least one persistent symptom after COVID-19 infection. Results: The median time interval between the last SARS-CoV-2 infection and emergency room presentation was 3 months. Older patients had comorbidities (61.7 vs. 44.9 years, p < 0.0001), moderate or severe forms of COVID-19 (61.2 vs. 50.9 years, p < 0.0001), and respiratory symptoms (56.1 vs. 52.0 years, p = 0.0027). Non-vaccinated patients were older than vaccinated patients (56.0 vs. 51.5 years, p = 0.0008) and had residual lung abnormalities following COVID-19 infection (51.5% vs. 36.8%, p < 0.003). The time interval between the last SARS-CoV-2 infection and the hospital evaluation was shorter for vaccinated patients (3.2 vs. 3.9 months, p < 0.0001) and those with mild forms (3.3 vs. 4.12 months, p = 0.0001) versus non-vaccinated individuals. After the last SARS-CoV-2 infection, 107 patients developed impaired fasting glucose, impaired glucose tolerance, or diabetes mellitus, being patients with already known chronic diseases (p = 0.0002), or hypertension (p = 0.001). Conclusions: Our study pointed out the heterogeneity of symptoms following COVID-19, and they are associated with age, vaccination status, or severity of SARS-CoV-2 infection.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19 症状持续存在并不定期回访 COVID-19 评估中心的患者特征。
研究背景这项回顾性研究旨在评估长 COVID 综合征患者的特征。研究方法本研究纳入了 457 名感染 COVID-19 后至少有一种持续症状的成年人。研究结果最后一次 SARS-CoV-2 感染与急诊就诊之间的中位时间间隔为 3 个月。年龄较大的患者有合并症(61.7 岁对 44.9 岁,P < 0.0001)、中度或重度 COVID-19 (61.2 岁对 50.9 岁,P < 0.0001)和呼吸道症状(56.1 岁对 52.0 岁,P = 0.0027)。未接种疫苗的患者比接种疫苗的患者年龄大(56.0 岁对 51.5 岁,p = 0.0008),感染 COVID-19 后肺部有残留异常(51.5% 对 36.8%,p < 0.003)。与未接种疫苗的患者相比,接种疫苗的患者(3.2 个月对 3.9 个月,p < 0.0001)和轻型患者(3.3 个月对 4.12 个月,p = 0.0001)从最后一次感染 SARS-CoV-2 到接受医院评估的时间间隔较短。在最后一次感染 SARS-CoV-2 后,107 名患者出现空腹血糖受损、糖耐量受损或糖尿病,其中包括已患有已知慢性疾病的患者(p = 0.0002)或高血压患者(p = 0.001)。结论我们的研究指出了 COVID-19 后症状的异质性,这些症状与年龄、疫苗接种情况或 SARS-CoV-2 感染的严重程度有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
0
审稿时长
6 weeks
期刊最新文献
Apixaban-Induced Esophagitis Dissecans Superficialis-Case Report and Literature Review. Characteristics of Hepatocellular Carcinoma by Sex in Mexico: A Multi-Institutional Collaboration. Clinical Significance of Whole-Body Computed Tomography Scans in Pediatric Out-of-Hospital Cardiac Arrest Patients Without Prehospital Return of Spontaneous Circulation. External Carotid Artery Entrapment by the Hyoid Bone Associated with an Atherosclerotic Stenosis of the Internal Carotid Artery. Inflammatory Prostatitis Plus IBS-D Subtype and Correlation with Immunomodulating Agent Imbalance in Seminal Plasma: Novel Combined Treatment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1